Gonorrhoea testing and positivity in non-remote Aboriginal Community Controlled Health Services.

Background Gonorrhoea occurs at high levels in young Aboriginal and Torres Strait Islander people living in remote communities, but there are limited data on urban and regional settings. An analysis was undertaken of gonorrhoea testing and positivity at four non-remote Aboriginal Community Controlled Health Services participating in a collaborative research network. METHODS This was a retrospective analysis of clinical encounter data derived from electronic medical records at participating services. Data were extracted using the GRHANITE program for all patients aged 15-54 years from 2009 to 2013. Demographic characteristics and testing and positivity for gonorrhoea were calculated for each year. RESULTS A total of 2971 patients (2571 Aboriginal and/or Torres Strait Islander) were tested for gonorrhoea during the study period. Among Aboriginal and/or Torres Strait Islander patients, 40 (1.6%) tested positive. Gonorrhoea positivity was associated with clinic location (higher in the regional clinic) and having had a positive chlamydia test. By year, the proportion of patients aged 15-29 years tested for gonorrhoea increased in both men (7.4% in 2009 to 15.9% in 2013) and women (14.8% in 2009 to 25.3% in 2013). Concurrent testing for chlamydia was performed on 86.3% of testing occasions, increasing from 75% in 2009 to 92% in 2013. Factors related to concurrent testing were sex and year of test. CONCLUSIONS The prevalence of gonorrhoea among young Aboriginal and/or Torres Strait Islander people in non-remote settings suggests that the current approach of duplex testing for chlamydia and gonorrhoea simultaneously is justified, particularly for women.

[1]  J. Hocking,et al.  Gonorrhoea notifications and nucleic acid amplification testing in a very low‐prevalence Australian female population , 2015, The Medical journal of Australia.

[2]  R. Guy,et al.  Increased testing for Neisseria gonorrhoeae with duplex nucleic acid amplification tests in Australia: implications for surveillance. , 2015, Sexual health.

[3]  J. Kaldor,et al.  Incidence of curable sexually transmissible infections among adolescents and young adults in remote Australian Aboriginal communities: analysis of longitudinal clinical service data , 2014, Sexually Transmitted Infections.

[4]  J. Kaldor,et al.  Epidemiology of gonorrhoea notifications in Australia, 2007-12. , 2014, Sexual health.

[5]  M. Ferson,et al.  Gonorrhoea infection, reinfection and co‐infection in men in inner Sydney: a population‐based analysis , 2014, The Medical journal of Australia.

[6]  Monica Lahra.  Australian Gonococcal Surveillance Programme annual report, 2012. , 2013, Communicable diseases intelligence quarterly report.

[7]  R. Guy,et al.  Epidemiology of chlamydia and gonorrhoea among Indigenous and non‐Indigenous Australians, 2000–2009 , 2012, The Medical journal of Australia.

[8]  Monica Lahra,et al.  The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. , 2012, The Journal of antimicrobial chemotherapy.

[9]  F. Ndowa,et al.  The threat of untreatable gonorrhoea: implications and consequences for reproductive and sexual morbidity , 2012, Reproductive health matters.

[10]  Douglas Boyle,et al.  A Systematic Mechanism for the Ethical Collection and Interpretation of Display Format Pathology Test Results from Australian Primary Care Records , 2011 .

[11]  A. McNulty,et al.  Neisseria gonorrhoeae infection in urban Sydney women: prevalence and predictors. , 2009, Sexual health.

[12]  S. Garland,et al.  Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia. , 1999, Sexually transmitted infections.